These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia. Veltri EP; Reid PR; Platia EV; Griffith LS Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872 [TBL] [Abstract][Full Text] [Related]
48. [Clinical experience in the treatment of tachyarrhythmias with amiodarone]. Sun JP Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Mar; 11(1):2-5. PubMed ID: 6884199 [No Abstract] [Full Text] [Related]
49. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429 [TBL] [Abstract][Full Text] [Related]
50. More on amiodarone for ventricular tachyarrhythmias. Nademanee K; Singh BH N Engl J Med; 1982 May; 306(19):1175. PubMed ID: 7070422 [No Abstract] [Full Text] [Related]
51. Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response. Strasberg B; Arditti A; Sclarovsky S; Lewin RF; Buimovici B; Agmon J Int J Cardiol; 1985 Jan; 7(1):47-58. PubMed ID: 4055134 [TBL] [Abstract][Full Text] [Related]
52. Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. Kuo CS; Reddy CP; Paciotti MV J Electrocardiol; 1985 Jan; 18(1):105-9. PubMed ID: 3882871 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up. Peter T; Hamer A; Mandel WJ; Weiss D Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841 [TBL] [Abstract][Full Text] [Related]
54. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. McAlister HF; Luke RA; Whitlock RM; Smith WM J Thorac Cardiovasc Surg; 1990 May; 99(5):911-8. PubMed ID: 2184287 [TBL] [Abstract][Full Text] [Related]
55. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
56. Electrophysiologic effects of amiodarone in tachyarrhythmias. Liu PH; Lin CC; Ko GC; Wang DJ; Shieh SM; Sung PK Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):759-75. PubMed ID: 3864917 [No Abstract] [Full Text] [Related]
57. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation. Heger JJ; Prystowsky EN; Miles WM; Zipes DP Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256 [No Abstract] [Full Text] [Related]
58. Adverse reactions during treatment with amiodarone hydrochloride. McGovern B; Garan H; Kelly E; Ruskin JN Br Med J (Clin Res Ed); 1983 Jul; 287(6386):175-80. PubMed ID: 6409240 [TBL] [Abstract][Full Text] [Related]
59. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. Gosselink AT; Crijns HJ; Van Gelder IC; Hillige H; Wiesfeld AC; Lie KI JAMA; 1992 Jun; 267(24):3289-93. PubMed ID: 1597910 [TBL] [Abstract][Full Text] [Related]